Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment

Dual block HER2 assessment can effectively increase the HER2 positive rate in resected specimens of gastric cancer (GC). The aim of this study is to explore whether GC patients with extra gained HER2 positivity by dual block assessment can benefit from trastuzumab therapy. Twenty-eight GC patients r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Aging (Albany NY)
Main Authors: Xu, Chen, Liu, Yalan, Jiang, Dongxian, Ge, Xiaowen, Huang, Jie, Su, Jieakesu, Zhang, Xue, Lu, Shaohua, Ji, Yuan, Hou, Jun, Liu, Tianshu, Hou, Yingyong
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals 2019
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6914406/
https://ncbi.nlm.nih.gov/pubmed/31739285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.102415
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares